AMERISAFE, Inc. logo AMSF - AMERISAFE, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 3
HOLD 3
SELL 0
STRONG
SELL
0
| PRICE TARGET: $33.50 DETAILS
HIGH: $40.00
LOW: $27.00
MEDIAN: $33.50
CONSENSUS: $33.50
UPSIDE: 33.68%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Undervalued Strong
Trading 58.7% below fair value
Current Price $25.06
Bear Case $49.74 98.5% upside ($49.74 - $25.06) / $25.06 = 98.5% ROTCE 15.3% → 4.00x TBV
Fair Value $60.70 142.2% upside ($60.70 - $25.06) / $25.06 = 142.2% ROTCE 20.5% → 4.00x TBV
Bull Case $78.90 214.9% upside ($78.90 - $25.06) / $25.06 = 214.9% ROTCE 23.5% → 4.00x TBV

Adjust Assumptions

20.5%
6.0%

Key Value Driver

ROTCE (20.5%) vs. cost of equity (6.0%)

Implied Market Multiple 2.02x

Plain-Language Summary

With ROTCE of 20.5% vs. 6.0% cost of equity, fair P/TBV is 4.00x on $12.44 tangible book, implying $60.70 per share.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (6 analysts) $33.50
Analyst Range $27.00 – $40.00
Divergence from AlphaVal 81%

Warnings

⚠ Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
⚠ Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
ℹ Wall Street's average price target is $33.50 (from 6 analysts). Our estimate is 81% above the consensus -- consider that gap carefully.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly